Specialty Drug
Amjevita is part of the TNF Blockers class and treats Rheumatoid Arthritis, Psoriasis, Ulcerative Colitis, and other conditions. TNF blockers are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. They work by reducing swelling of the joints and skin. Amjevita is only available as a brand name drug. Compare TNF blockers.

Amjevita Latest News

Get the latest updates on this drug from the GoodRx medical team

FDA Approves Second Humira Biosimilar

Roni Shye - September 14, 2017

Cyltezo (adalimumab-adbm) is the newest biosimilar for the second biggest selling drug of 2015 – Humira. This is the second biosimilar for Humira, coming after the approval of Amjevita in 2016. 

What is a biosimilar?

Without getting too technical, biosimilars are basically the generic product of a biologic (a medication made from a living organism). However, because these medications are made out of living cells they are slightly different. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.
Safe Pharmacy